INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $24,000 | -64.7% | 1,946 | -70.2% | 0.00% | -71.4% |
| Q1 2017 | $68,000 | +126.7% | 6,534 | +246.8% | 0.01% | +40.0% |
| Q1 2016 | $30,000 | -70.0% | 1,884 | -46.5% | 0.01% | -70.6% |
| Q4 2015 | $100,000 | -45.9% | 3,520 | -46.1% | 0.02% | -46.9% |
| Q3 2015 | $185,000 | +172.1% | 6,532 | +243.8% | 0.03% | +166.7% |
| Q2 2015 | $68,000 | -6.8% | 1,900 | +8.5% | 0.01% | -47.8% |
| Q4 2014 | $73,000 | +49.0% | 1,751 | +9.4% | 0.02% | +187.5% |
| Q2 2014 | $49,000 | – | 1,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |